The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed)
Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate.
Pain in the adjacent areas of the teeth.
Derivatives of BENZOIC ACID that contain one or more amino groups attached to the benzene ring structure. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include the aminobenzoate structure.
Batrachotoxin is the 20-alpha-bromobenzoate of batrachotoxin A; they are toxins from the venom of a small Colombian frog, Phyllobates aurotaenia, cause release of acetylcholine, destruction of synaptic vesicles and depolarization of nerve and muscle fibers.
A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
Inflammation of the DENTAL PULP, usually due to bacterial infection in dental caries, tooth fracture, or other conditions causing exposure of the pulp to bacterial invasion. Chemical irritants, thermal factors, hyperemic changes, and other factors may also cause pulpitis.
Chloramines are chemical compounds formed by the reaction between ammonia and chlorine, often used as disinfectants in water treatment but can also form in swimming pools, posing potential respiratory and mucous membrane irritation risks.
A surface anesthetic that acts by preventing transmission of impulses along NERVE FIBERS and at NERVE ENDINGS.
A carrier or inert medium used as a solvent (or diluent) in which the medicinally active agent is formulated and or administered. (Dictionary of Pharmacy, 1986)
Benzoic acids, salts, or esters that contain an amino group attached to carbon number 4 of the benzene ring structure.
A delayed rectifier subtype of shaker potassium channels that conducts a delayed rectifier current. It contributes to ACTION POTENTIAL repolarization of MYOCYTES in HEART ATRIA.
Investigations conducted on the physical health of teeth involving use of a tool that transmits hot or cold electric currents on a tooth's surface that can determine problems with that tooth based on reactions to the currents.
A local anesthetic of the ester type that has a slow onset and a short duration of action. It is mainly used for infiltration anesthesia, peripheral nerve block, and spinal block. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1016).
Tosyl compounds are organic derivatives characterized by the introduction of a tosyl group, which is the sulfonate ester of p-toluenesulfonic acid (CH3C6H4SO3H), into an organic molecule through a substitution reaction.
Methyl, propyl, butyl, and ethyl esters of p-hydroxybenzoic acid. They have been approved by the FDA as antimicrobial agents for foods and pharmaceuticals. (From Hawley's Condensed Chemical Dictionary, 11th ed, p872)
A potent local anesthetic of the ester type used for surface and spinal anesthesia.
A local anesthetic of the amide type now generally used for surface anesthesia. It is one of the most potent and toxic of the long-acting local anesthetics and its parenteral use is restricted to spinal anesthesia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1006)
A blocking of nerve conduction to a specific area by an injection of an anesthetic agent.
The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example.
A range of methods used to reduce pain and anxiety during dental procedures.
Colloids with a solid continuous phase and liquid as the dispersed phase; gels may be unstable when, due to temperature or other cause, the solid phase liquefies; the resulting colloid is called a sol.
Ion channels that specifically allow the passage of SODIUM ions. A variety of specific sodium channel subtypes are involved in serving specialized functions such as neuronal signaling, CARDIAC MUSCLE contraction, and KIDNEY function.
Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects.
Scales, questionnaires, tests, and other methods used to assess pain severity and duration in patients or experimental animals to aid in diagnosis, therapy, and physiological studies.
A widely used local anesthetic agent.
A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23.
Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol.
Potassium channel whose permeability to ions is extremely sensitive to the transmembrane potential difference. The opening of these channels is induced by the membrane depolarization of the ACTION POTENTIAL.
The parts of a macromolecule that directly participate in its specific combination with another molecule.
The opening and closing of ion channels due to a stimulus. The stimulus can be a change in membrane potential (voltage-gated), drugs or chemical transmitters (ligand-gated), or a mechanical deformation. Gating is thought to involve conformational changes of the ion channel which alters selective permeability.
A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.
Cell membrane glycoproteins that are selectively permeable to potassium ions. At least eight major groups of K channels exist and they are made up of dozens of different subunits.
An electrophysiologic technique for studying cells, cell membranes, and occasionally isolated organelles. All patch-clamp methods rely on a very high-resistance seal between a micropipette and a membrane; the seal is usually attained by gentle suction. The four most common variants include on-cell patch, inside-out patch, outside-out patch, and whole-cell clamp. Patch-clamp methods are commonly used to voltage clamp, that is control the voltage across the membrane and measure current flow, but current-clamp methods, in which the current is controlled and the voltage is measured, are also used.
An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
Elements of limited time intervals, contributing to particular results or situations.
The rate dynamics in chemical or physical systems.

Efficacy of mandibular topical anesthesia varies with the site of administration. (1/88)

This study compared the threshold of pain sensitivity in the anterior mandibular mucobuccal fold with the posterior. This was followed by a comparison of the reduction of needle insertion pain in the anterior mucobuccal fold and the pterygo-temporal depression by either topical anesthesia or nitrous oxide inhalation. The pain threshold was determined by an analgometer, a pain-measuring device that depends on pressure readings; additionally, pain caused by a needle inserted by a normal technique was assessed using a visual analog scale (VAS). The threshold of pain was significantly lower in the incisor and canine regions than in the premolar and the molar regions (P < 0.001). Compared to a placebo, topical anesthesia significantly reduced the pain from needle insertion in the mucobuccal fold adjacent to the mandibular canine (P < 0.001), but did not significantly reduce pain in the pterygotemporal depression. The addition of 30% nitrous oxide did not significantly alter pain reduction compared to a control of 100% oxygen. These results suggest that topical anesthesia application may be effective in reducing the pain of needle insertion in the anterior mandibular mucobuccal fold, but may not be as effective for a standard inferior alveolar nerve block. The addition of 30% nitrous oxide did not lead to a significant improvement.  (+info)

Local anesthetic anchoring to cardiac sodium channels. Implications into tissue-selective drug targeting. (2/88)

Local anesthetics inhibit Na+ channels in a variety of tissues, leading to potentially serious side effects when used clinically. We have created a series of novel local anesthetics by connecting benzocaine (BZ) to the sulfhydryl-reactive group methanethiosulfonate (MTS) via variable-length polyethylether linkers (L) (MTS-LX-BZ [X represents 0, 3, 6, or 9]). The application of MTS-LX-BZ agents modified native rat cardiac as well as heterologously expressed human heart (hH1) and rat skeletal muscle (rSkM1) Na+ channels in a manner resembling that of free BZ. Like BZ, the effects of MTS-LX-BZ on rSkM1 channels were completely reversible. In contrast, MTS-LX-BZ modification of heart and mutant rSkM1 channels, containing a pore cysteine at the equivalent location as cardiac Na+ channels (ie, Y401C), persisted after drug washout unless treated with DTT, which suggests anchoring to the pore via a disulfide bond. Anchored MTS-LX-BZ competitively reduced the affinity of cardiac Na+ channels for lidocaine but had minimal effects on mutant channels with disrupted local anesthetic modification properties. These results establish that anchored MTS-LX-BZ compounds interact with the local anesthetic binding site (LABS). Variation in the linker length altered the potency of channel modification by the anchored drugs, thus providing information on the spatial relationship between the anchoring site and the LABS. Our observations demonstrate that local anesthetics can be anchored to the extracellular pore cysteine in cardiac Na+ channels and dynamically interact with the intracellular LABS. These results suggest that nonselective agents, such as local anesthetics, might be made more selective by linking these agents to target-specific anchors.  (+info)

Benzocaine enhances and inhibits the K+ current through a human cardiac cloned channel (Kv1.5). (3/88)

OBJECTIVE: The aim of this study was to analyze the effects of a neutral local anaesthetic, benzocaine, on a cardiac K+ channel cloned from human ventricle. METHODS: Experiments were performed on hKv1.5 channels stably expressed on mouse cells using the whole-cell configuration of the patch clamp technique. RESULTS: At 10 nM, benzocaine increased the current amplitude ("agonist effect") by shifting the activation curve 8.4 +/- 2.7 mV in the negative direction, and slowed the time course of tail current decline. In contrast, benzocaine (100-700 microM) inhibited hKv1.5 currents (KD = 901 +/- 81 microM), modified the voltage-dependence of channel activation, which became biphasic, and accelerated the channel deactivation. Extracellular K+ concentration ([K+]o) also affected the channel gating. At 140 mM [K+]o, the time course of tail currents deactivation was significantly accelerated, whereas at 0 mM [K+]o, it was slowed. At both [K+]o the activation curve became biphasic. Benzocaine accelerated the tail current decay at 0 mM but not at 140 mM [K+]o. The reduction in the permeation of K+ through the pore did not modify the blocking effects of micromolar concentrations of benzocaine, but suppressed the agonist effect observed at nanomolar concentrations. CONCLUSIONS: All these results suggest that benzocaine blocks and modifies the voltage- and time-dependent properties of hKv1.5 channels, binding to an extracellular and to an intracellular site at the channel level. Moreover, both sites are related to each other and can also interact with K+.  (+info)

Selective block of late Na(+) current by local anaesthetics in rat large sensory neurones. (4/88)

The actions of lignocaine and benzocaine on transient and late Na(+) current generated by large diameter (> or =50 microm) adult rat dorsal root ganglion neurones, were studied using patch-clamp techniques. Both drugs blocked whole-cell late Na(+) current in a concentration-dependent manner. At 200 ms following the onset of a clamp step from -110 to -40 mV, the apparent K for block of late Na(+) current by lignocaine was 57.8+/-15 microM (mean+/-s.e.mean, n = 4). The value for benzocaine was 24.9+/-3.3 microM, (mean+/-s.e. mean, n = 3). The effect of lignocaine on transient current, in randomly selected neurones, appeared variable (n = 8, half-block from approximately 50 to 400 microM). Half-block by benzocaine was not attained, but both whole-cell (n = 11) and patch data suggested a high apparent K,>250 microM. Transient current always remained after late current was blocked. The voltage-dependence of residual late current steady-state inactivation was not shifted by 20 microM benzocaine (n = 3), whereas 200 microM benzocaine shifted the voltage-dependence of transient current steady-state inactivation by -18.7+/-5.9 mV (mean+/-s.e.mean, n = 4). In current-clamp, benzocaine (250 microM) could block subthreshold, voltage-dependent inward current, increasing the threshold for eliciting action potentials, without preventing their generation (n = 2). Block of late Na(+) current by systemic local anaesthetic may play a part in preventing ectopic impulse generation in sensory neurones.  (+info)

Local anesthetic inhibition of m1 muscarinic acetylcholine signaling. (5/88)

BACKGROUND: Local anesthetics inhibit lipid mediator signaling (lysophosphatidate, thromboxane) by acting on intracellular domains of the receptor or on the G protein. On receptors for polar agonists, the ligand-binding pocket could form an additional site of interaction, possibly resulting in superadditive inhibition. The authors therefore investigated the effects of local anesthetics on m1 muscarinic receptor functioning. METHODS: The authors expressed receptors in isolation using Xenopus oocytes. Using a two-electrode voltage clamp, the authors measured the effects of lidocaine, QX314 (permanently charged), and benzocaine (permanently uncharged) on Ca2+-activated Cl- currents elicited by methylcholine. The authors also characterized the interaction of lidocaine with [3H] quinuclydinyl benzylate ([3H]QNB) binding to m1 receptors. RESULTS: Lidocaine inhibited muscarinic signaling with a half-maximal inhibitory concentration (IC50 18 nm) 140-fold less than that of extracellularly administered QX314 (IC50 2.4 microm). Intracellularly injected QX314 (IC50 0.96 mm) and extracellularly applied benzocaine (IC50 1.2 mm) inhibited at high concentrations only. Inhibition of muscarinic signaling by extracellularly applied QX314 and lidocaine was the result of noncompetitive antagonism. Intracellularly injected QX314 and benzocaine inhibited muscarinic and lysophosphatidate signaling at similar concentrations, suggesting an action on the common G-protein pathway. Combined administration of intracellularly injected (IC50 19 microm) and extracellularly applied QX314 (IC50 49 nm) exerted superadditive inhibition. Lidocaine did not displace specific [3H]QNB binding to m1 receptors. CONCLUSIONS: m1 Muscarinic signaling is inhibited by clinically relevant concentrations of lidocaine and by extracellularly administered QX314, suggesting that the major site of action is a extracellular domain of the muscarinic receptor. An additional less potent but superadditive inhibitory effect on the G-protein is suggested.  (+info)

Modulation of gastric distension-induced sensations by small intestinal receptors. (6/88)

Duodenal lipid exacerbates gastrointestinal sensations during gastric distension. Using luminal application of the local anesthetic benzocaine, we investigated the role of intestinal receptors in the induction of these sensations. Nine healthy subjects were studied on five occasions, during which isotonic saline or 20% lipid (2 kcal/min), combined with (duodenal or jejunal) 0.75% benzocaine or vehicle at 2.5 ml/min, was infused intraduodenally before and during gastric distension. Intragastric pressures and volumes, gastrointestinal sensations, and plasma CCK levels were determined. Duodenal lipid combined with vehicle increased gastric volume (in ml: saline, -10 +/- 18; lipid/vehicle, 237 +/- 30) and plasma CCK [mean levels (pmol/l): saline, 2.0 +/- 0. 2; lipid/vehicle, 8.0 +/- 1.6] and, during distensions, induced nausea (scores: saline, 3 +/- 2: lipid/vehicle, 58 +/- 19) and decreased pressures at which fullness and discomfort occurred. Duodenal but not jejunal benzocaine attenuated the effect of lipid on gastric volume, plasma CCK, and nausea during distension (135 +/- 38 and 216 +/- 40 ml, 4.6 +/- 0.6 pmol/l and not assessed, and 37 +/- 12 and 64 +/- 21 for lipid + duodenal benzocaine and lipid + jejunal benzocaine, respectively) and on pressures for sensations. In conclusion, intestinal receptors modulate gastrointestinal sensations associated with duodenal lipid and gastric distension. There is also the potential for local neural mechanisms to regulate CCK release and thereby reduce afferent activation indirectly.  (+info)

Inhibition of m3 muscarinic acetylcholine receptors by local anaesthetics. (7/88)

1. Muscarinic m1 receptors are inhibited by local anaesthetics (LA) at nM concentrations. To elucidate in more detail the site(s) of LA interaction, we compared these findings with LA effects on m3 muscarinic receptors. 2. We expressed receptors in Xenopus oocytes. Using two-electrode voltage clamp, we measured the effects of lidocaine, QX314 (permanently charged) and benzocaine (permanently uncharged) on Ca(2+)-activated Cl(-)-currents (I(Cl(Ca))), elicited by acetyl-beta-methylcholine bromide (MCh). We also characterized the interaction of lidocaine with [(3)H]-quinuclydinyl benzylate ([(3)H]-QNB) binding to m3 receptors. Antisense-injection was used to determine the role of specific G-protein alpha subunits in mediating the inhibitory effects of LA. Using chimeric receptor constructs we investigated which domains of the muscarinic receptors contribute to the binding site for LA. 3. Lidocaine inhibited m3-signalling in a concentration-dependent, reversible, non-competitive manner with an IC(50) of 370 nM, approximately 21 fold higher than the IC(50) (18 nM) reported for m1 receptors. Intracellular inhibition of both signalling pathways by LA was similar, and dependent on the G(q)- protein alpha subunit. In contrast to results reported for the m1 receptor, the m3 receptor lacks the major extracellular binding site for charged LA. The N-terminus and third extracellular loop of the m1 muscarinic receptor molecule were identified as requirements to obtain extracellular inhibition by charged LA.  (+info)

Clinical effectiveness of lidocaine and benzocaine for topical anesthesia. (8/88)

The effectiveness of lidocaine and benzocaine in reducing pain produced by needle insertion into the palate was evaluated in a double-blind and placebo-controlled study using a more suitable method. Twenty subjects, 10 men and 10 women, submitted to 4 sessions in which they were randomly treated with 5% lidocaine, a placebo that tasted like lidocaine, 20% benzocaine, and a placebo that tasted like benzocaine. At each session, a 27-gauge needle was inserted into the palate twice, once before (baseline) and once after drug application for 1 minute. Immediately after each insertion, subjects indicated on a visual analog scale the pain intensity perceived. Lidocaine and benzocaine were equally efficient, and both were better than placebo in reducing pain caused by insertion of needles into the palate.  (+info)

Methemoglobinemia is a medical condition characterized by an increased level of methemoglobin in the blood. Methemoglobin is a form of hemoglobin that cannot effectively transport oxygen throughout the body due to the iron atom within its structure being oxidized from the ferrous (Fe2+) state to the ferric (Fe3+) state.

Under normal circumstances, methemoglobin levels are kept below 1% of total hemoglobin. However, when these levels rise above 10%, it can lead to symptoms such as shortness of breath, headache, fatigue, and cyanosis (a bluish discoloration of the skin and mucous membranes). Severe methemoglobinemia, with levels exceeding 50%, can result in life-threatening complications, including seizures, coma, and even death.

Methemoglobinemia can be congenital or acquired. Congenital methemoglobinemia is caused by genetic defects affecting the enzymes responsible for reducing methemoglobin back to its functional form, hemoglobin. Acquired methemoglobinemia can result from exposure to certain medications, chemicals, or toxins that oxidize hemoglobin and increase methemoglobin levels. Treatment typically involves administering methylene blue, a reducing agent that helps convert methemoglobin back to functional hemoglobin. In severe cases or when methylene blue is contraindicated, alternative treatments such as exchange transfusions or hyperbaric oxygen therapy may be considered.

Local anesthetics are a type of medication that is used to block the sensation of pain in a specific area of the body. They work by temporarily numbing the nerves in that area, preventing them from transmitting pain signals to the brain. Local anesthetics can be administered through various routes, including topical application (such as creams or gels), injection (such as into the skin or tissues), or regional nerve blocks (such as epidural or spinal anesthesia).

Some common examples of local anesthetics include lidocaine, prilocaine, bupivacaine, and ropivacaine. These medications can be used for a variety of medical procedures, ranging from minor surgeries (such as dental work or skin biopsies) to more major surgeries (such as joint replacements or hernia repairs).

Local anesthetics are generally considered safe when used appropriately, but they can have side effects and potential complications. These may include allergic reactions, toxicity (if too much is administered), and nerve damage (if the medication is injected into a nerve). It's important to follow your healthcare provider's instructions carefully when using local anesthetics, and to report any unusual symptoms or side effects promptly.

A toothache is defined as pain or discomfort in or around a tooth, usually caused by dental cavities, gum disease, tooth fracture, or exposed tooth roots. The pain may be sharp and stabbing, throbbing, or constant and dull. It can also be aggravated by hot, cold, sweet, or sour foods and drinks, or by biting or chewing. Toothaches are serious and should not be ignored as they can be a sign of more significant dental issues that require immediate professional attention from a dentist.

Aminobenzoates are a group of chemical compounds that contain an amino (NH2) group and a benzoate (C6H5COO-) group in their structure. They are widely used in the pharmaceutical and cosmetic industries due to their various properties, such as ultraviolet light absorption, antimicrobial activity, and anti-inflammatory effects.

One of the most well-known aminobenzoates is para-aminobenzoic acid (PABA), which is a naturally occurring compound found in some foods and also synthesized by bacteria in the human gut. PABA has been used as a topical sunscreen agent due to its ability to absorb ultraviolet B (UVB) radiation, but its use as a sunscreen ingredient has declined in recent years due to concerns about skin irritation and potential allergic reactions.

Other aminobenzoates have various medical uses, such as:

* Antimicrobial agents: Some aminobenzoates, such as benzalkonium chloride and cetylpyridinium chloride, are used as antiseptics and disinfectants due to their ability to disrupt bacterial cell membranes.
* Analgesic and anti-inflammatory agents: Aminobenzoates such as methyl salicylate and acetaminophen (paracetamol) are commonly used as pain relievers and fever reducers.
* Vitamin B supplements: PABA is a component of folic acid, which is an essential vitamin for human health. Some people take PABA supplements to treat or prevent various conditions, such as graying hair, rheumatoid arthritis, and vitiligo, although there is limited scientific evidence to support these uses.

It's important to note that some aminobenzoates can be toxic in high doses or with prolonged exposure, so they should be used under the guidance of a healthcare professional.

Batrachotoxins are a type of steroidal alkaloid toxin that are found in certain species of frogs, beetles, and plants. They are highly toxic and cause rapid excitation of nerve and muscle tissue leading to paralysis and death. Batrachotoxins work by irreversibly binding to and opening sodium ion channels in cell membranes, causing a persistent depolarization of the membrane potential. This leads to uncontrolled firing of action potentials in nerves and muscles, resulting in the symptoms mentioned above. These toxins are considered among the most potent natural poisons known.

Lidocaine is a type of local anesthetic that numbs painful areas and is used to prevent pain during certain medical procedures. It works by blocking the nerves that transmit pain signals to the brain. In addition to its use as an anesthetic, lidocaine can also be used to treat irregular heart rates and relieve itching caused by allergic reactions or skin conditions such as eczema.

Lidocaine is available in various forms, including creams, gels, ointments, sprays, solutions, and injectable preparations. It can be applied directly to the skin or mucous membranes, or it can be administered by injection into a muscle or vein. The specific dosage and method of administration will depend on the reason for its use and the individual patient's medical history and current health status.

Like all medications, lidocaine can have side effects, including allergic reactions, numbness that lasts too long, and in rare cases, heart problems or seizures. It is important to follow the instructions of a healthcare provider carefully when using lidocaine to minimize the risk of adverse effects.

Pulpitis is a dental term that refers to the inflammation of the pulp, which is the soft tissue inside the center of a tooth that contains nerves, blood vessels, and connective tissue. The pulp helps to form the dentin, the hard layer beneath the enamel. Pulpitis can result from tooth decay, dental trauma, or other factors that cause damage to the tooth's protective enamel and dentin layers, exposing the pulp to irritants and bacteria.

There are two types of pulpitis: reversible and irreversible. Reversible pulpitis is characterized by mild inflammation that can be treated and potentially reversed with dental intervention, such as a filling or root canal treatment. Irreversible pulpitis, on the other hand, involves severe inflammation that cannot be reversed, and typically requires a root canal procedure to remove the infected pulp tissue and prevent further infection or damage to the tooth.

Symptoms of pulpitis may include tooth sensitivity to hot or cold temperatures, pain or discomfort when biting down or applying pressure to the tooth, and in some cases, spontaneous or radiating pain. If left untreated, pulpitis can lead to more serious dental issues, such as abscesses or bone loss around the affected tooth.

Chloramines are a group of compounds that consist of chlorine combined with ammonia and nitrogen. In the context of water treatment, chloramines are often formed when ammonia is added to water that has been treated with chlorine. This process is known as chloramination and is used as a secondary disinfection method to help control microbial growth in drinking water distribution systems.

Chloramines have several advantages over chlorine alone as a disinfectant. They are more stable and persist for longer periods in the distribution system, which helps to maintain a residual disinfectant concentration throughout the system. This is important because it provides ongoing protection against microbial growth and contamination.

However, chloramines can also have some disadvantages. They may react with organic matter in the water to form disinfection byproducts (DBPs), which can be harmful to human health. Chloramines can also cause corrosion of pipes and other infrastructure in the distribution system, leading to leaching of metals such as lead and copper into the water.

Overall, chloramination is a widely used and effective method for disinfecting drinking water, but it must be carefully monitored and managed to ensure that it is done safely and effectively.

Benzocaine is a local anesthetic agent that works by numbing the skin or mucous membranes to block pain signals from reaching the brain. It is commonly used as a topical medication in the form of creams, gels, sprays, lozenges, and ointments to relieve pain associated with minor cuts, burns, sunburn, sore throat, mouth ulcers, and other conditions that cause discomfort or irritation.

Benzocaine works by temporarily reducing the sensitivity of nerve endings in the affected area, which helps to alleviate pain and provide a soothing effect. It is generally considered safe when used as directed, but it can have some side effects such as skin irritation, stinging, burning, or allergic reactions.

It's important to note that benzocaine products should not be used on deep wounds, puncture injuries, or serious burns, and they should not be applied to large areas of the body or used for prolonged periods without medical supervision. Overuse or misuse of benzocaine can lead to rare but serious side effects such as methemoglobinemia, a condition that affects the oxygen-carrying capacity of the blood.

"Pharmaceutical vehicles" is not a standard term in medical or pharmaceutical sciences. However, I can provide some context based on the phrase's possible meaning. If by "pharmaceutical vehicles," you mean the carriers or delivery systems for drugs or medications, then the definition would be:

Pharmaceutical vehicles refer to various formulations, preparations, or technologies that facilitate and control the administration of a drug or therapeutic agent to its target site in the body. These can include different types of drug delivery systems such as tablets, capsules, liposomes, nanoparticles, transdermal patches, inhalers, injectables, and other innovative drug carrier technologies.

These pharmaceutical vehicles ensure that the active ingredients are safely and effectively transported to their intended site of action within the body, enhancing therapeutic efficacy while minimizing potential side effects.

Para-aminobenzoates are a group of compounds that contain a para-aminobenzoic acid (PABA) molecule. PABA is an organic compound that is related to benzoic acid and aminobenzoic acid. It is not an essential nutrient for humans, but it does play a role in the metabolism of certain bacteria.

Para-aminobenzoates are often used as ingredients in sunscreens because PABA absorbs ultraviolet (UV) light and can help protect the skin from sun damage. However, para-aminobenzoates can cause skin irritation and allergic reactions in some people, so they have largely been replaced by other UV-absorbing compounds in modern sunscreens.

In addition to their use in sunscreens, para-aminobenzoates are also used in the treatment of various medical conditions. For example, they may be used as a topical agent to treat fungal infections or as a systemic therapy to treat rheumatoid arthritis and other inflammatory conditions.

It is important to note that para-aminobenzoates should not be confused with paracetamol (also known as acetaminophen), which is a commonly used pain reliever and fever reducer. While both compounds contain the word "para," they are chemically distinct and have different uses in medicine.

The Kv1.5 potassium channel, also known as KCNA5, is a type of voltage-gated potassium channel that is widely expressed in various tissues, including the heart and blood vessels. It plays a crucial role in regulating electrical excitability and maintaining physiological functions in these tissues.

In the heart, Kv1.5 channels are primarily located in the atria and contribute to the repolarization phase of the cardiac action potential. They help establish the rapid delayed rectifier current (IKr), which is essential for normal atrial electrical activity and maintaining proper heart rhythm. Mutations or dysfunctions in Kv1.5 channels can lead to various cardiac arrhythmias, such as atrial fibrillation.

In blood vessels, Kv1.5 channels are involved in the regulation of vascular tone and blood pressure. They contribute to the hyperpolarization of vascular smooth muscle cells, which leads to vasodilation and decreased peripheral resistance. Dysregulation of Kv1.5 channels has been implicated in several cardiovascular diseases, including hypertension and atherosclerosis.

Overall, Kv1.5 potassium channels are critical for maintaining proper electrical activity in the heart and regulating vascular tone, making them an important target for therapeutic interventions in various cardiovascular disorders.

A dental pulp test is a medical procedure used to determine if the pulp of a tooth is alive or dead. The pulp is the soft tissue inside the tooth that contains nerves, blood vessels, and connective tissue. There are several types of dental pulp tests, including:

1. Cold Test: This involves applying a cold stimulus to the tooth using a substance such as ice or a cold spray. A healthy pulp will respond to the cold by causing a brief, sharp pain. If the pulp is dead or damaged, there will be no response to the cold.
2. Heat Test: This involves applying a heat stimulus to the tooth using a hot substance such as gutta-percha or a hot water bath. A healthy pulp will respond to the heat by causing a brief, sharp pain. If the pulp is dead or damaged, there will be no response to the heat.
3. Electric Pulp Test: This involves applying a low-level electrical current to the tooth. A healthy pulp will respond to the electrical current by causing a tingling or buzzing sensation. If the pulp is dead or damaged, there will be no response to the electrical current.

The results of these tests can help dental professionals determine if a tooth needs root canal treatment or if it can be saved with other treatments.

Procaine is a local anesthetic drug that is used to reduce the feeling of pain in a specific area of the body. It works by blocking the nerves from transmitting painful sensations to the brain. Procaine is often used during minor surgical procedures, dental work, or when a patient needs to have a wound cleaned or stitched up. It can also be used as a diagnostic tool to help determine the source of pain.

Procaine is administered via injection directly into the area that requires anesthesia. The effects of procaine are relatively short-lived, typically lasting between 30 minutes and two hours, depending on the dose and the individual's metabolism. Procaine may also cause a brief period of heightened sensory perception or euphoria following injection, known as "procaine rush."

It is important to note that procaine should only be administered by trained medical professionals, as improper use can lead to serious complications such as allergic reactions, respiratory depression, and even death.

Tosyl compounds are organic compounds that contain the tosyl group (p-toluenesulfonyl, -SO2C6H4CH3) as a substituent. The tosyl group is a protecting group or a good leaving group in organic reactions. Tosyl compounds are often prepared by reacting alcohols or amines with p-toluenesulfonyl chloride (TsCl) in the presence of a base.

The general formula for a tosyl compound can be represented as R-OTs, where R represents an organic group such as an alkyl, aryl, or heteroaryl group. Tosyl compounds are widely used in organic synthesis due to their versatility and reactivity.

Parabens are a group of synthetic preservatives that have been widely used in the cosmetics and personal care product industry since the 1920s. They are effective at inhibiting the growth of bacteria, yeasts, and molds, which helps to prolong the shelf life of these products. Parabens are commonly found in shampoos, conditioners, lotions, creams, deodorants, and other personal care items.

The most commonly used parabens include methylparaben, ethylparaben, propylparaben, and butylparaben. These compounds are often used in combination to provide broad-spectrum protection against microbial growth. Parabens work by penetrating the cell wall of microorganisms and disrupting their metabolism, which prevents them from multiplying.

Parabens have been approved for use as preservatives in cosmetics and personal care products by regulatory agencies around the world, including the U.S. Food and Drug Administration (FDA) and the European Commission's Scientific Committee on Consumer Safety (SCCS). However, there has been some controversy surrounding their safety, with concerns raised about their potential to mimic the hormone estrogen in the body and disrupt normal endocrine function.

While some studies have suggested that parabens may be associated with health problems such as breast cancer and reproductive toxicity, the evidence is not conclusive, and more research is needed to fully understand their potential risks. In response to these concerns, many manufacturers have begun to remove parabens from their products or offer paraben-free alternatives. It's important to note that while avoiding parabens may be a personal preference for some individuals, there is currently no scientific consensus on the need to avoid them entirely.

Tetracaine is a local anesthetic commonly used for surface anesthesia of the eye, ear, and mucous membranes. It functions by blocking the nerve impulses in the area where it's applied, thereby numbing the area and relieving pain. It's available in various forms such as solutions, ointments, and sprays. Please note that all medical procedures and treatments should be conducted under the supervision of a healthcare professional.

Dibucaine is a local anesthetic drug that is used to numb the skin or mucous membranes before medical procedures. It works by blocking the nerve signals in the area where it is applied, preventing the sensation of pain. Dibucaine is available as a topical cream, ointment, or gel, and it may also be used as an ingredient in lozenges or throat sprays to relieve sore throats.

Dibucaine has been largely replaced by other local anesthetics due to its potential for causing allergic reactions and other side effects. It is important to follow your healthcare provider's instructions carefully when using dibucaine, and to inform them of any medical conditions or medications you are taking that may interact with the drug.

Local anesthesia is a type of anesthesia that numbs a specific area of the body, blocking pain signals from that particular region while allowing the person to remain conscious and alert. It is typically achieved through the injection or application of a local anesthetic drug, which works by temporarily inhibiting the function of nerve fibers carrying pain sensations. Common examples of local anesthetics include lidocaine, prilocaine, and bupivacaine.

Local anesthesia is commonly used for minor surgical procedures, dental work, or other medical interventions where only a small area needs to be numbed. It can also be employed as part of a combined anesthetic technique, such as in conjunction with sedation or regional anesthesia, to provide additional pain relief and increase patient comfort during more extensive surgeries.

The duration of local anesthesia varies depending on the type and dosage of the anesthetic agent used; some last for just a few hours, while others may provide numbness for up to several days. Overall, local anesthesia is considered a safe and effective method for managing pain during various medical procedures.

Topical administration refers to a route of administering a medication or treatment directly to a specific area of the body, such as the skin, mucous membranes, or eyes. This method allows the drug to be applied directly to the site where it is needed, which can increase its effectiveness and reduce potential side effects compared to systemic administration (taking the medication by mouth or injecting it into a vein or muscle).

Topical medications come in various forms, including creams, ointments, gels, lotions, solutions, sprays, and patches. They may be used to treat localized conditions such as skin infections, rashes, inflammation, or pain, or to deliver medication to the eyes or mucous membranes for local or systemic effects.

When applying topical medications, it is important to follow the instructions carefully to ensure proper absorption and avoid irritation or other adverse reactions. This may include cleaning the area before application, covering the treated area with a dressing, or avoiding exposure to sunlight or water after application, depending on the specific medication and its intended use.

Dental anesthesia is a type of local or regional anesthesia that is specifically used in dental procedures to block the transmission of pain impulses from the teeth and surrounding tissues to the brain. The most common types of dental anesthesia include:

1. Local anesthesia: This involves the injection of a local anesthetic drug, such as lidocaine or prilocaine, into the gum tissue near the tooth that is being treated. This numbs the area and prevents the patient from feeling pain during the procedure.
2. Conscious sedation: This is a type of minimal sedation that is used to help patients relax during dental procedures. The patient remains conscious and can communicate with the dentist, but may not remember the details of the procedure. Common methods of conscious sedation include nitrous oxide (laughing gas) or oral sedatives.
3. Deep sedation or general anesthesia: This is rarely used in dental procedures, but may be necessary for patients who are extremely anxious or have special needs. It involves the administration of drugs that cause a state of unconsciousness and prevent the patient from feeling pain during the procedure.

Dental anesthesia is generally safe when administered by a qualified dentist or oral surgeon. However, as with any medical procedure, there are risks involved, including allergic reactions to the anesthetic drugs, nerve damage, and infection. Patients should discuss any concerns they have with their dentist before undergoing dental anesthesia.

In medical terms, "gels" are semi-solid colloidal systems in which a solid phase is dispersed in a liquid medium. They have a viscous consistency and can be described as a cross between a solid and a liquid. The solid particles, called the gel network, absorb and swell with the liquid component, creating a system that has properties of both solids and liquids.

Gels are widely used in medical applications such as wound dressings, drug delivery systems, and tissue engineering due to their unique properties. They can provide a moist environment for wounds to heal, control the release of drugs over time, and mimic the mechanical properties of natural tissues.

Sodium channels are specialized protein structures that are embedded in the membranes of excitable cells, such as nerve and muscle cells. They play a crucial role in the generation and transmission of electrical signals in these cells. Sodium channels are responsible for the rapid influx of sodium ions into the cell during the initial phase of an action potential, which is the electrical signal that travels along the membrane of a neuron or muscle fiber. This sudden influx of sodium ions causes the membrane potential to rapidly reverse, leading to the depolarization of the cell. After the action potential, the sodium channels close and become inactivated, preventing further entry of sodium ions and helping to restore the resting membrane potential.

Sodium channels are composed of a large alpha subunit and one or two smaller beta subunits. The alpha subunit forms the ion-conducting pore, while the beta subunits play a role in modulating the function and stability of the channel. Mutations in sodium channel genes have been associated with various inherited diseases, including certain forms of epilepsy, cardiac arrhythmias, and muscle disorders.

Anti-infective agents, local, are medications that are applied directly to a specific area of the body to prevent or treat infections caused by bacteria, fungi, viruses, or parasites. These agents include topical antibiotics, antifungals, antivirals, and anti-parasitic drugs. They work by killing or inhibiting the growth of the infectious organisms, thereby preventing their spread and reducing the risk of infection. Local anti-infective agents are often used to treat skin infections, eye infections, and other localized infections, and can be administered as creams, ointments, gels, solutions, or drops.

Pain measurement, in a medical context, refers to the quantification or evaluation of the intensity and/or unpleasantness of a patient's subjective pain experience. This is typically accomplished through the use of standardized self-report measures such as numerical rating scales (NRS), visual analog scales (VAS), or categorical scales (mild, moderate, severe). In some cases, physiological measures like heart rate, blood pressure, and facial expressions may also be used to supplement self-reported pain ratings. The goal of pain measurement is to help healthcare providers better understand the nature and severity of a patient's pain in order to develop an effective treatment plan.

Bupivacaine is a long-acting local anesthetic drug, which is used to cause numbness or loss of feeling in a specific area of the body during certain medical procedures such as surgery, dental work, or childbirth. It works by blocking the nerves that transmit pain signals to the brain.

Bupivacaine is available as a solution for injection and is usually administered directly into the tissue surrounding the nerve to be blocked (nerve block) or into the spinal fluid (epidural). The onset of action of bupivacaine is relatively slow, but its duration of action is long, making it suitable for procedures that require prolonged pain relief.

Like all local anesthetics, bupivacaine carries a risk of side effects such as allergic reactions, nerve damage, and systemic toxicity if accidentally injected into a blood vessel or given in excessive doses. It should be used with caution in patients with certain medical conditions, including heart disease, liver disease, and neurological disorders.

Sodium is an essential mineral and electrolyte that is necessary for human health. In a medical context, sodium is often discussed in terms of its concentration in the blood, as measured by serum sodium levels. The normal range for serum sodium is typically between 135 and 145 milliequivalents per liter (mEq/L).

Sodium plays a number of important roles in the body, including:

* Regulating fluid balance: Sodium helps to regulate the amount of water in and around your cells, which is important for maintaining normal blood pressure and preventing dehydration.
* Facilitating nerve impulse transmission: Sodium is involved in the generation and transmission of electrical signals in the nervous system, which is necessary for proper muscle function and coordination.
* Assisting with muscle contraction: Sodium helps to regulate muscle contractions by interacting with other minerals such as calcium and potassium.

Low sodium levels (hyponatremia) can cause symptoms such as confusion, seizures, and coma, while high sodium levels (hypernatremia) can lead to symptoms such as weakness, muscle cramps, and seizures. Both conditions require medical treatment to correct.

A placebo is a substance or treatment that has no inherent therapeutic effect. It is often used in clinical trials as a control against which the effects of a new drug or therapy can be compared. Placebos are typically made to resemble the active treatment, such as a sugar pill for a medication trial, so that participants cannot tell the difference between what they are receiving and the actual treatment.

The placebo effect refers to the phenomenon where patients experience real improvements in their symptoms or conditions even when given a placebo. This may be due to psychological factors such as belief in the effectiveness of the treatment, suggestion, or conditioning. The placebo effect is often used as a comparison group in clinical trials to help determine if the active treatment has a greater effect than no treatment at all.

Voltage-gated potassium channels are a type of ion channel found in the membrane of excitable cells such as nerve and muscle cells. They are called "voltage-gated" because their opening and closing is regulated by the voltage, or electrical potential, across the cell membrane. Specifically, these channels are activated when the membrane potential becomes more positive, a condition that occurs during the action potential of a neuron or muscle fiber.

When voltage-gated potassium channels open, they allow potassium ions (K+) to flow out of the cell down their electrochemical gradient. This outward flow of K+ ions helps to repolarize the membrane, bringing it back to its resting potential after an action potential has occurred. The precise timing and duration of the opening and closing of voltage-gated potassium channels is critical for the normal functioning of excitable cells, and abnormalities in these channels have been linked to a variety of diseases, including cardiac arrhythmias, epilepsy, and neurological disorders.

In the context of medical and biological sciences, a "binding site" refers to a specific location on a protein, molecule, or cell where another molecule can attach or bind. This binding interaction can lead to various functional changes in the original protein or molecule. The other molecule that binds to the binding site is often referred to as a ligand, which can be a small molecule, ion, or even another protein.

The binding between a ligand and its target binding site can be specific and selective, meaning that only certain ligands can bind to particular binding sites with high affinity. This specificity plays a crucial role in various biological processes, such as signal transduction, enzyme catalysis, or drug action.

In the case of drug development, understanding the location and properties of binding sites on target proteins is essential for designing drugs that can selectively bind to these sites and modulate protein function. This knowledge can help create more effective and safer therapeutic options for various diseases.

Ion channel gating refers to the process by which ion channels in cell membranes open and close in response to various stimuli, allowing ions such as sodium, potassium, and calcium to flow into or out of the cell. This movement of ions is crucial for many physiological processes, including the generation and transmission of electrical signals in nerve cells, muscle contraction, and the regulation of hormone secretion.

Ion channel gating can be regulated by various factors, including voltage changes across the membrane (voltage-gated channels), ligand binding (ligand-gated channels), mechanical stress (mechanosensitive channels), or other intracellular signals (second messenger-gated channels). The opening and closing of ion channels are highly regulated and coordinated processes that play a critical role in maintaining the proper functioning of cells and organ systems.

The double-blind method is a study design commonly used in research, including clinical trials, to minimize bias and ensure the objectivity of results. In this approach, both the participants and the researchers are unaware of which group the participants are assigned to, whether it be the experimental group or the control group. This means that neither the participants nor the researchers know who is receiving a particular treatment or placebo, thus reducing the potential for bias in the evaluation of outcomes. The assignment of participants to groups is typically done by a third party not involved in the study, and the codes are only revealed after all data have been collected and analyzed.

Potassium channels are membrane proteins that play a crucial role in regulating the electrical excitability of cells, including cardiac, neuronal, and muscle cells. These channels facilitate the selective passage of potassium ions (K+) across the cell membrane, maintaining the resting membrane potential and shaping action potentials. They are composed of four or six subunits that assemble to form a central pore through which potassium ions move down their electrochemical gradient. Potassium channels can be modulated by various factors such as voltage, ligands, mechanical stimuli, or temperature, allowing cells to fine-tune their electrical properties and respond to different physiological demands. Dysfunction of potassium channels has been implicated in several diseases, including cardiac arrhythmias, epilepsy, and neurodegenerative disorders.

Patch-clamp techniques are a group of electrophysiological methods used to study ion channels and other electrical properties of cells. These techniques were developed by Erwin Neher and Bert Sakmann, who were awarded the Nobel Prize in Physiology or Medicine in 1991 for their work. The basic principle of patch-clamp techniques involves creating a high resistance seal between a glass micropipette and the cell membrane, allowing for the measurement of current flowing through individual ion channels or groups of channels.

There are several different configurations of patch-clamp techniques, including:

1. Cell-attached configuration: In this configuration, the micropipette is attached to the outer surface of the cell membrane, and the current flowing across a single ion channel can be measured. This configuration allows for the study of the properties of individual channels in their native environment.
2. Whole-cell configuration: Here, the micropipette breaks through the cell membrane, creating a low resistance electrical connection between the pipette and the inside of the cell. This configuration allows for the measurement of the total current flowing across all ion channels in the cell membrane.
3. Inside-out configuration: In this configuration, the micropipette is pulled away from the cell after establishing a seal, resulting in the exposure of the inner surface of the cell membrane to the solution in the pipette. This configuration allows for the study of the properties of ion channels in isolation from other cellular components.
4. Outside-out configuration: Here, the micropipette is pulled away from the cell after establishing a seal, resulting in the exposure of the outer surface of the cell membrane to the solution in the pipette. This configuration allows for the study of the properties of ion channels in their native environment, but with the ability to control the composition of the extracellular solution.

Patch-clamp techniques have been instrumental in advancing our understanding of ion channel function and have contributed to numerous breakthroughs in neuroscience, pharmacology, and physiology.

Potassium is a essential mineral and an important electrolyte that is widely distributed in the human body. The majority of potassium in the body (approximately 98%) is found within cells, with the remaining 2% present in blood serum and other bodily fluids. Potassium plays a crucial role in various physiological processes, including:

1. Regulation of fluid balance and maintenance of normal blood pressure through its effects on vascular tone and sodium excretion.
2. Facilitation of nerve impulse transmission and muscle contraction by participating in the generation and propagation of action potentials.
3. Protein synthesis, enzyme activation, and glycogen metabolism.
4. Regulation of acid-base balance through its role in buffering systems.

The normal serum potassium concentration ranges from 3.5 to 5.0 mEq/L (milliequivalents per liter) or mmol/L (millimoles per liter). Potassium levels outside this range can have significant clinical consequences, with both hypokalemia (low potassium levels) and hyperkalemia (high potassium levels) potentially leading to serious complications such as cardiac arrhythmias, muscle weakness, and respiratory failure.

Potassium is primarily obtained through the diet, with rich sources including fruits (e.g., bananas, oranges, and apricots), vegetables (e.g., leafy greens, potatoes, and tomatoes), legumes, nuts, dairy products, and meat. In cases of deficiency or increased needs, potassium supplements may be recommended under the guidance of a healthcare professional.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

In the context of medicine and pharmacology, "kinetics" refers to the study of how a drug moves throughout the body, including its absorption, distribution, metabolism, and excretion (often abbreviated as ADME). This field is called "pharmacokinetics."

1. Absorption: This is the process of a drug moving from its site of administration into the bloodstream. Factors such as the route of administration (e.g., oral, intravenous, etc.), formulation, and individual physiological differences can affect absorption.

2. Distribution: Once a drug is in the bloodstream, it gets distributed throughout the body to various tissues and organs. This process is influenced by factors like blood flow, protein binding, and lipid solubility of the drug.

3. Metabolism: Drugs are often chemically modified in the body, typically in the liver, through processes known as metabolism. These changes can lead to the formation of active or inactive metabolites, which may then be further distributed, excreted, or undergo additional metabolic transformations.

4. Excretion: This is the process by which drugs and their metabolites are eliminated from the body, primarily through the kidneys (urine) and the liver (bile).

Understanding the kinetics of a drug is crucial for determining its optimal dosing regimen, potential interactions with other medications or foods, and any necessary adjustments for special populations like pediatric or geriatric patients, or those with impaired renal or hepatic function.

Topex metered spray (benzocaine 20%) prescribing information. Englewood, NJ; 2006. Benzocaine topical "Antipyrine-Benzocaine ... Examples of combination medications of benzocaine include: Antipyrine-benzocaine otic consists of antipyrine and benzocaine, ... The melting point of benzocaine is 88-92 °C, and the boiling point is about 310 °C. The density of benzocaine is 1.17 g/cm3. ... Treatment of benzocaine with hydrazine leads to aminostimil, a compound related to isoniazid. Benzocaine can be prepared by ...
"ANTIPYRINE WITH BENZOCAINE - OTIC". MedicineNet.com. "Auralgan (Antipyrine, Benzocaine, and Glygerin dehydrated) Drug ... Antipyrine and benzocaine ear drops is a medication for the treatment of ear pain caused by otitis media. It combines ... Each 1 ml of A/B otic drops contains: Antipyrine 54 mg Benzocaine 14 mg Glycerin and Hydroxyquinoline Sulfate USP A/B otic ... In 2008, Auralgan was reformulated to include acetic acid and U-polycosanol 410, in addition to antipyrine and benzocaine. Due ...
Wahlergebnisse, accessed October 21, 2012 "Benzocaine". Wikimedia Commons has media related to: Eberbach (Baden) (category) (in ... inventor of Benzocaine Eberbach (Baden) is twinned with: Thonon-les-Bains, France Ephrata, United States Aktuelle ...
"Antipyrine-Benzocaine Otic: MedlinePlus Drug Information". medlineplus.gov. Retrieved 2022-07-26. "Regulations.gov". www. ... A common over-the-counter product sold as Auralgan contained antipyrine (analgesic) and benzocaine (anesthetic). It was ...
"Benzocaine-Benzyl Benzoate Topical: Side Effects". WebMD. 2016. Archived from the original on 19 October 2016. Retrieved 19 ...
Other similar compounds are procaine and benzocaine. Denatonium in humans is recognized by eight distinct bitter taste ...
Other Chloraseptic formulas are based on benzocaine. Chloraseptic was invented and originally made by Robert Schattner; it was ...
Benzocaine applied to the gums or throat (as commonly used in baby teething gels, or sore throat lozenges) can cause ... Exposure to exogenous oxidizing drugs and their metabolites (such as benzocaine, dapsone, and nitrates) may lead to an increase ... Substances involved may include benzocaine, nitrates, or dapsone. The underlying mechanism involves some of the iron in ... benzocaine, prilocaine, and lidocaine), and aniline dyes, metoclopramide, rasburicase, umbellulone, chlorates, bromates, and ...
Local anesthetics such as benzocaine, however, are contraindicated. Schwellnus et al. state that topical steroids (such as ...
The esters include benzocaine, procaine, tetracaine, and chloroprocaine. The amides include lidocaine, mepivacaine, prilocaine ...
... and benzocaine. Relationships between age, sex, history of exposure, and reactivity to standard patch tests and use tests in a ...
... or child-safe pain-relief treatments containing benzocaine, lidocaine, or choline salicylate. Benzocaine must be used ... For example, applying a gel of 20% benzocaine in polyethylene glycol may give only a modest benefit over applying the placebo, ... benzocaine gels and liquids applied to the gums or mouth". U.S. Food and Drug Administration. April 7, 2011. Retrieved December ...
There are pain relief pads sopping with alcohol and benzocaine. These pads are good for treating minor scrapes, burns, and ...
Medical portal Lozenges may contain benzocaine, an anaesthetic, or eucalyptus oil. Non-menthol throat lozenges generally use ...
This may include paracetamol (acetaminophen), ibuprofen, benzocaine ear drops, or opioids. In AOM, antibiotics may speed ... Topical agents shown to be effective include antipyrine and benzocaine ear drops. Decongestants and antihistamines, either ...
Its main competitors have been benzocaine and other benzocaine-based drugs. The use of Cetacaine has allowed for faster in and ... Benzocaine-based anesthetics (which includes Cetacaine) have started to come scrutiny by the FDA. In 2006 the FDA has announced ... Cetacaine is a benzocaine-based anesthetic that also contains other active ingredients that include butamben and tetracaine ... The FDA also during this time started to take many Benzocaine based drugs that were not approved off the market and fining ...
ISBN 0-08-040296-8. Minard R (18 October 2006). "The Preparation of the Local Anesthetic, Benzocaine, by an Esterification ...
It is generally safe to use in those allergic to tetracaine or benzocaine. Lidocaine is an antiarrhythmic medication of the ...
Products containing benzocaine can numb all body parts with which they come in contact. In the United States, the first ... Additionally, a commonly used numbing agent benzocaine can cause an allergic reaction in those with an allergy to PABA (4- ...
Irritation: Can be caused by fragrances, neomycin (adhesive on pads), tea tree oil, benzocaine. Inflammation can also be a risk ...
External, topical treatments include the anesthetic benzocaine, the antihistamine diphenhydramine, and the corticosteroid ...
doi:10.1111/j.1095-8649.1975.tb04587.x. Laird, Lindsay M.; Oswald, R. L. (1975). "A Note on the use of Benzocaine (Ethyl P- ... A Note on the use of benzocaine(Ethyl P-Aminobenzoate) as a fish anaesthetic. Aquaculture Research, Vol 6 (4) 92-94 1980. Field ... She also published key papers on basic techniques now considered routine: freeze branding of juvenile salmon, and benzocaine as ...
The major active ingredients of the sugar-free lozenges are cetylpyridinium chloride, benzocaine (which produces the numbing ... In the US, the Cēpacol lozenges have benzocaine while the mouthwash has Cetylpyridinium chloride. "CEPACOL SORE THROAT". ... Cepacaine lozenges contains lignocaine and cetylpyridinium chloride, and Cepacaine mouthwash contains benzocaine and ...
Vilke GM, Jin A, Davis DP, Chan TC (July 2004). "Prospective randomized study of viscous lidocaine versus benzocaine in a GI ... single-blind study performed by Vike and Davis compared treatment with antacids plus either viscous lidocaine or benzocaine ...
Benzocaine or lidocaine are typically used for this purpose as they are available as over-the-counter drugs. The duration of ... Examples include benzocaine, butamben, dibucaine, lidocaine, oxybuprocaine, pramoxine, proxymetacaine (proparacaine), and ...
Benzocaine is a permanently uncharged species that inhibits the receptor by plugging the pore of the opened channel. Tetracaine ... Benzocaine and tetracaine are also local anesthetics that have an inhibitory effect on the muscle‐type nicotinic receptor. ... "Mechanisms of Blockade of the Muscle-Type Nicotinic Receptor by Benzocaine, a Permanently Uncharged Local Anesthetic". ...
Topical anesthetic treatments such as prilocaine, lidocaine, benzocaine, or tetracaine can also relieve itching and pain. ...
"The analgesic effect of benzocaine mucoadhesive patches on orthodontic pain caused by elastomeric separators, a preliminary ...
It can be congenital or caused by medications, food additives or toxins, including chloroquine, benzene, nitrites, benzocaine. ...
A topical anesthetic containing benzocaine will relieve pain quickly and menthol is an effective anti-itch treatment. Itching ...
Topex metered spray (benzocaine 20%) prescribing information. Englewood, NJ; 2006. Benzocaine topical "Antipyrine-Benzocaine ... Examples of combination medications of benzocaine include: Antipyrine-benzocaine otic consists of antipyrine and benzocaine, ... The melting point of benzocaine is 88-92 °C, and the boiling point is about 310 °C. The density of benzocaine is 1.17 g/cm3. ... Treatment of benzocaine with hydrazine leads to aminostimil, a compound related to isoniazid. Benzocaine can be prepared by ...
Antipyrine-Benzocaine Otic: learn about side effects, dosage, special precautions, and more on MedlinePlus ... Antipyrine and benzocaine otic comes as a solution (liquid) to place into the ear. When antipyrine and benzocaine is used to ... Antipyrine and benzocaine are in a class of medications called analgesics. The combination of antipyrine and benzocaine works ... Before using antipyrine and benzocaine otic,. *tell your doctor and pharmacist if you are allergic to antipyrine or benzocaine ...
... its best to choose wisely between benzocaine and lidocaine, as they have different properties. ... One main difference between benzocaine and lidocaine is that benzocaine can be acquired without a doctors prescription, while ... Benzocaine Vs. Lidocaine: Whats The Difference?. NEWS EXCLUSIVES ROYALS BEAUTY STYLE WELLNESS LOVE LIVING POLITICS ... Because of benzocaines less severe nature as a product, it is more suitable for soft tissues and mucous membranes such as the ...
BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5) BENZOCAINE. 200 mg in 1 g. ... HURRICAINE TOPICAL ANESTHETIC- benzocaine spray. To receive this label RSS feed. Copy the URL below and paste it into your RSS ... HURRICAINE TOPICAL ANESTHETIC- benzocaine spray. If this SPL contains inactivated NDCs listed by the FDA initiated compliance ... Allergy alert: Do not use if you have a history of allergy to local anesthetics such as procaine, butacaine, benzocaine or ...
Easy-to-read patient leaflet for Benzocaine Topical Stick. Includes indications, proper use, special instructions, precautions ... Benzocaine Topical Stick. Generic name: Benzocaine Topical Stick [ BEN-zoe-kane ]. Brand name: Aftertest Topical Pain Relief. ... Benzocaine topical side effects (more detail). What are some other side effects of Benzocaine Topical Stick?. All drugs may ... What do I need to tell my doctor BEFORE I take Benzocaine Topical Stick?. *If you have an allergy to benzocaine or any other ...
Benzocaine/Menthol Topical Spray 20%/0.5% Benzocaine/Menthol Topical Spray 20%/0.5%. This medicine is used for the following ...
... children and adults who used oral benzocaine products after 2007 and suffered from methemoglobinemia. ... Home News Dangerous Prescription Drugs Lawyers Accepting Benzocaine Methemoglobinemia Lawsuits. Lawyers Accepting Benzocaine ... FDA Advises Against Benzocaine-Use in Infants. In May 2018, the FDA warned that over-the-counter oral benzocaine products ... Benzocaine Products for Teething, Tooth & Mouth Pain. Parents use benzocaine products on the gums of teething infants. Adults ...
Specter represents adults and children who have suffered methemoglobinemia caused by benzocaine - Anbesol, Orajel - nationwide ... Benzocaine is used by physicians in medical procedures to numb the mucous membranes in the mouth and throat. Over-the-counter ... Contact a benzocaine attorney today.. Learn more about methemoglobinemia from the National Center for Biotechnology Information ... The U.S. Food and Drug Administration reported in April 2011 that use of benzocaine in products such as Anbesol, Orajel, Baby ...
BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5) BENZOCAINE. 20 g in 100 g. ... TOPCO 4X MEDICATED TOOTHACHE AND GUM GEL- benzocaine gel. To receive this label RSS feed. Copy the URL below and paste it into ... benzalkonium chloride 0.0013 MG/MG / benzocaine 0.2 MG/MG / menthol 0.005 MG/MG / zinc chloride 0.0015 MG/MG Oral Gel. SCD. ... TOPCO 4X MEDICATED TOOTHACHE AND GUM GEL- benzocaine gel. If this SPL contains inactivated NDCs listed by the FDA initiated ...
BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5) BENZOCAINE. 20 g in 100 g. ... WELL AT WALGREENS ANTI-ITCH MAXIMUM STRENGTH- benzocaine and resorcinol cream. To receive this label RSS feed. Copy the URL ... WELL AT WALGREENS ANTI-ITCH MAXIMUM STRENGTH- benzocaine and resorcinol cream. If this SPL contains inactivated NDCs listed by ... WELL AT WALGREENS ANTI-ITCH MAXIMUM STRENGTH- benzocaine and resorcinol cream. Number of versions: 2. ...
D04AB54 - Benzocaine, combinations. Pharmaceutical companies: manufacturers, researchers, developers, local distributors and ...
... products containing benzocaine, a local anesthetic. Benzocaine is the active ingredient in many OTC gels, sprays, liquids and ... According to the FDA, parents and caregivers should not use benzocaine products on children under two years of age, except ... For more information on the FDAs safety announcement regarding benzocaine, click here. Parenting.com has also posted an ... Not only is Camilia benzocaine-free, it does not contain preservatives, flavors, dyes, sugar or artificial sweeteners. Its ...
Topical Benzocaine and Methemoglobinemia. American journal of therapeutics 2017;24;e596-e598 2017 An Uncommon Complication With ... Benzocaine-induced methemoglobinemia. Anesthesia progress 2005;52;136-9 2005 Acquired methemoglobinemia: a retrospective series ... Benzocaine-induced methemoglobinemia: report of a severe reaction and review of the literature. The Annals of pharmacotherapy ... Benzocaine and lidocaine induced methemoglobinemia after bronchoscopy: a case report. Journal of medical case reports 2008 Jan ...
Benzocaine is also sold in other forms such as lozenges and spray solutions (also see separate Drug Safety Communication on ... Benzocaine gels and liquids are sold OTC under different brand names such as Anbesol, Hurricaine, Orajel, Baby Orajel, Orabase ... The U.S. Food and Drug Administration (FDA) is warning the public that the use of benzocaine, the main ingredient in over-the- ... FDA alerts public to reports of serious adverse effects with use of benzocaine sprays, gels. Posted on May 13, 2011 ...
Further information: Benzocaine (topical) and Benzocaine (topical). Further information: Benzocaine (injection) and ... Retrieved from "https://www.wikidoc.org/index.php?title=Benzocaine&oldid=1097333" ...
You are viewing an interactive 3D depiction of the molecule benzocaine (C9H11NO2) from the PQR. ...
What Are The Uses Of Benzocaine Materials? The benzocaine anesthetic is used to get out from the numbing and pains. It is ... In this solution, the gram starting range is 250 to 1000 grams varieties is supply benzocaine reduces the body injury. Visit- ... Does anyone suffer the pains and itching? Do order for benzocaine online shopping and free door delivery. Visit- https:// ...
Oh Benzocaine. Oh Benzocaine. Oh Benzocaine. Oh Benzocaine. Chalk white. Gobshite. Bleeding gums. I thought the Benzocaine was ... Benzocaine lyrics. Oh Benzocaine. I think its a crime. That when you look in your babys eyes. You wont see mine. You wont ... letra de Benzocaine. Benzocaine songtekst. Benzocaine testo. Benzocaine paroles. Info. Benzocaine est une chanson interprétée ... Paroles de la chanson Benzocaine par Idles. ...
Benzocaine benzocaine at a low price benzocaine buy benzocaine fluffy benzocaine for sale benzocaine in the UK benzocaine ... for sale Benzocaine powder online benzocaine powder uk benzocaine powder UK sale benzocaine price benzocaine uk benzocaine uk ... buy benzocaine powder buy benzocaine powder uk buy benzocaine uk buy benzocaine uk paypal buy boric acid UK cheap benzocaine ... benzocaine where can i buy benzocaine where can I buy benzocaine powder where to buy benzocaine where to buy pure benzocaine in ...
Benzocaine. Avoid topical use of benzocaine. Benzocaine is included in most standard patch test trays. Individuals allergic to ... benzocaine may safely use or be injected with lidocaine (Xylocaine), which does not cross-react with benzocaine. ...
You can just research the term "get benzocaine UK PayPal" to search out merchants in the United Kingdom that do. We also use ... third-party cookies that assist us evaluate and understand https://rcchemsupply.net/product/buy-benzocaine-powder/. ...
Oh Benzocaine. Oh Benzocaine. Oh Benzocaine. Oh Benzocaine. Chalk white. Gobshite. Bleeding gums. I thought the Benzocaine was ... Benzocaine lyrics. Oh Benzocaine. I think its a crime. That when you look in your babys eyes. You wont see mine. You wont ... letra de Benzocaine. Benzocaine songtekst. Benzocaine testo. Benzocaine paroles. Información. Benzocaine es una canción ... Letra y video de Benzocaine de Idles. ...
... exporter of Benzocaine Ip offered by REMEDY LABS at latest price from Ahmedabad, Gujarat. Get more information on our website. ... Other Products in Benzocaine category. Benzocaine Gel 4.2. Color : White. Molecular Weight : 165.189 Grams (g). Usage : For ... Benzocaine Gel 9%. Color : White. Molecular Weight : 201.65 Grams (g). Usage : For Pharmaceutical Industry Use. Form : Powder. ... Benzocaine Usp. Color : White. Molecular Weight : 201.65 Grams (g). Usage : For Pharmaceutical Industry Use. Form : Powder. ...
Benzocaine, বেনজোকেইন. byMusic Bus BD •. July 07, 2017. • 2 min read ...
Benzocaine is used short term to relieve pain from minor mouth problems (such as toothache, canker sores, sore gums/throat, ... Before using benzocaine, tell your doctor or pharmacist if you are allergic to it; or to other "caine" anesthetics (such as ...
... tinay222vmc1 112 days ago News Discuss ... benzocaine-powder-buy56690.canariblogs.com/the-best-side-of-benzocaine-powder-buy-34641677. ... Non-vital Non-essential Ones body may possibly take in more of benzocaine topical https:// ...
Powerect Benzocaine Delay Serum Foil 3ml (with POS) Premature Ejaculation (PE) affects 1 in 3 men at some point during their ...
copyright 2015 - 2023 Magnet Research Chemical , All Rights Reserved. ...

No FAQ available that match "benzocaine"

No images available that match "benzocaine"